Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI)

Q: What does CUSIP 68236X100 represent in this 13F holders report?

CUSIP 68236X100 is the security identifier for TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share used to aggregate holder disclosures.

Q: How many institutions held TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share in Q2 2022?

33 institutional investors reported TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: 68236X100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding: 99,175,922
Total 13F shares: 21,874,386
Share change: +700,723
Total reported value: $110,684,000
Price per share: $5.06
Number of holders: 33
Value change: +$2,844,383
Number of buys: 22
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 68236X100?
CUSIP 68236X100 identifies TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 68236X100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TOI - Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	12%	12,000,000	$85,560,000	—	31 Mar 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	— mixed-class rows	4,546,107 mixed-class rows	$33,575,000	—	31 Mar 2022	13F
Redmile Group, LLC	13F	Company	2.4%	2,414,432	$17,215,000	—	31 Mar 2022	13F
LMR Partners LLP	13F	Company	— class O/S missing	1,023,991	$7,301,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.85%	838,321	$5,977,000	—	31 Mar 2022	13F
Velan Capital Investment Management LP	13F	Company	0.6%	600,000	$4,278,000	—	31 Mar 2022	13F
Parian Global Management LP	13F	Company	0.45%	444,244	$3,167,000	—	31 Mar 2022	13F
Triatomic Management LP	13F	Company	0.43%	428,100	$3,052,000	—	31 Mar 2022	13F
Saba Capital Management, L.P.	13F	Company	0.4%	400,000	$2,852,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.16%	159,823	$1,140,000	—	31 Mar 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.11%	106,505	$759,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.08%	80,402	$573,000	—	31 Mar 2022	13F
Empery Asset Management, LP	13F	Company	0.07%	70,733	$504,000	—	31 Mar 2022	13F
James E. Flynn	3/4/5	Possible Members of 10% Group, 10%+ Owner	— mixed-class rows	7,887,160 mixed-class rows	$448,270	—	12 Nov 2021	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.06%	60,387	$431,000	—	31 Mar 2022	13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	13F	Company	— class O/S missing	318,710	$367,000	—	31 Mar 2022	13F
Alpine Global Management, LLC	13F	Company	— mixed-class rows	65,975 mixed-class rows	$321,000	—	31 Mar 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.04%	37,850	$270,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.03%	31,100	$222,000	—	31 Mar 2022	13F
Jefferies Group LLC	13F	Company	— class O/S missing	155,457	$178,776	—	31 Mar 2022	13F
DIFESA CAPITAL MANAGEMENT, LP	13F	Company	— class O/S missing	125,000	$144,000	—	31 Mar 2022	13F
Union Square Park Capital Management, LLC	13F	Company	— class O/S missing	120,000	$138,000	—	31 Mar 2022	13F
J.P. Morgan Private Wealth Advisors LLC	13F	Company	0.02%	18,300	$130,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.02%	18,065	$129,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	— class O/S missing	94,740	$109,000	—	31 Mar 2022	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	— class O/S missing	91,966	$105,000	—	31 Mar 2022	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	— class O/S missing	87,500	$101,000	—	31 Mar 2022	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.01%	10,873	$78,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	10,033	$72,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	9,638	$69,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0%	4,475	$33,000	—	31 Mar 2022	13F
TENOR CAPITAL MANAGEMENT Co., L.P.	13F	Company	— class O/S missing	25,000	$29,000	—	31 Mar 2022	13F
Penserra Capital Management LLC	13F	Company	0%	3,050	$21,000	—	31 Mar 2022	13F
Ovata Capital Management Ltd	13F	Company	0%	1,100	$8,000	—	31 Mar 2022	13F
State of Wyoming	13F	Company	0%	967	$7,000	—	31 Mar 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	815	$6,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	— class O/S missing	4,474	$5,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0%	579	$4,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0%	400	$3,000	—	31 Mar 2022	13F
DFP Sponsor LLC	3/4/5	Possible Members of 10% Group, 10%+ Owner	— mixed-class rows	3,177,583 mixed-class rows	$5	—	12 Nov 2021	3/4/5
Richy Agajanian	3/4/5	10%+ Owner	— class O/S missing	296,075	—	—	10 Jun 2022	3/4/5
Scott Dalgleish	3/4/5	Chief Financial Officer	— class O/S missing	162,891	—	—	21 Mar 2022	3/4/5

Institutional Holders of Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) as of Q2 2022

As of 30 Jun 2022, Oncology Institute, Inc. - Common Stock, $0.0001 Par Value Per Share (TOI) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,874,386 shares. The largest 10 holders included FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Velan Capital Investment Management LP, Saba Capital Management, L.P., Triatomic Management LP, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.